VIKING GLOBAL INVESTORS LP 13D and 13G filings for BioMarin Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-09-30 4:29 pm Purchase |
2024-09-20 | 13G | BioMarin Pharmaceutical Inc. BMRN |
VIKING GLOBAL INVESTORS LP | 9,753,293 5.100% |
9,753,293 (New Position) |
Filing |